Lipid and carbohydrate metabolism share scores of common regulators, so mutations in these regulators may disturb both metabolic pathways.
1. |
Suhre K et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. |
2. |
Vaxillaire M et al. (1994) Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. |
3. |
Warner JP et al. (1995) Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization. |
4. |
Hayward BE et al. (1996) Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23. |
5. |
Hayward BE et al. (1998) Organization of the human glucokinase regulator gene GCKR. |
6. |
Farrelly D et al. (1999) Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. |
7. |
Grimsby J et al. (2000) Characterization of glucokinase regulatory protein-deficient mice. |
10. |
Beer NL et al. (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. |
11. |
Dupuis J et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. |
12. |
Lloyd DJ et al. (2013) Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors. |